These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 15166496)

  • 21. Vascular endothelial growth factor assessment in different blood fractions of gastrointestinal cancer patients and healthy controls.
    Ranieri G; Coviello M; Chiriatti A; Stea B; Montemurro S; Quaranta M; Dittadi R; Paradiso A
    Oncol Rep; 2004 Feb; 11(2):435-9. PubMed ID: 14719080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: a key to study an angiogenic marker in vivo?
    Wynendaele W; Derua R; Hoylaerts MF; Pawinski A; Waelkens E; de Bruijn EA; Paridaens R; Merlevede W; van Oosterom AT
    Ann Oncol; 1999 Aug; 10(8):965-71. PubMed ID: 10509160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum vascular endothelial growth factor-C and vascular endothelial growth factor level in patients with colorectal carcinoma and clinical significance.
    Xu T; Chen D
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(3):329-31, 355. PubMed ID: 16961284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
    Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G
    Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?
    George ML; Eccles SA; Tutton MG; Abulafi AM; Swift RI
    Clin Cancer Res; 2000 Aug; 6(8):3147-52. PubMed ID: 10955796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Shift in the balance between circulating thrombospondin-1 and vascular endothelial growth factor in cancer patients: relationship to platelet alpha-granule content and primary activation.
    Gonzalez FJ; Rueda A; Sevilla I; Alonso L; Villarreal V; Torres E; Alba E
    Int J Biol Markers; 2004; 19(3):221-8. PubMed ID: 15503824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High levels of circulating VEGFR2+ Bone marrow-derived progenitor cells correlate with metastatic disease in patients with pediatric solid malignancies.
    Taylor M; Rössler J; Geoerger B; Laplanche A; Hartmann O; Vassal G; Farace F
    Clin Cancer Res; 2009 Jul; 15(14):4561-71. PubMed ID: 19605404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Granulocyte colony-stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils.
    Ohki Y; Heissig B; Sato Y; Akiyama H; Zhu Z; Hicklin DJ; Shimada K; Ogawa H; Daida H; Hattori K; Ohsaka A
    FASEB J; 2005 Dec; 19(14):2005-7. PubMed ID: 16223785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia.
    Wierzbowska A; Robak T; Wrzesień-Kuś A; Krawczyńska A; Lech-Marańda E; Urbańska-Ryś H
    Eur Cytokine Netw; 2003; 14(3):149-53. PubMed ID: 14656688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of tumour and circulating vascular endothelial growth factor (VEGF) in patients with oesophagogastric cancer: a long-term follow-up study.
    Gray RT; O'Donnell ME; McGuigan JA; Spence GM
    Br J Biomed Sci; 2012; 69(2):71-5. PubMed ID: 22872931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of menopause and hysterectomy on systemic vascular endothelial growth factor in women undergoing surgery for breast cancer.
    Lowery AJ; Sweeney KJ; Molloy AP; Hennessy E; Curran C; Kerin MJ
    BMC Cancer; 2008 Sep; 8():279. PubMed ID: 18826631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer.
    Hyodo I; Doi T; Endo H; Hosokawa Y; Nishikawa Y; Tanimizu M; Jinno K; Kotani Y
    Eur J Cancer; 1998 Dec; 34(13):2041-5. PubMed ID: 10070308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of plasma vascular endothelial growth factor in patients with hepatocellular carcinoma and effect of transcatheter arterial chemoembolization therapy on plasma vascular endothelial growth factor level.
    Li X; Feng GS; Zheng CS; Zhuo CK; Liu X
    World J Gastroenterol; 2004 Oct; 10(19):2878-82. PubMed ID: 15334691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of angiogenesis regulatory proteins and epithelial-mesenchymal transition factors in platelets of the breast cancer patients.
    Han H; Cao FL; Wang BZ; Mu XR; Li GY; Wang XW
    ScientificWorldJournal; 2014; 2014():878209. PubMed ID: 25379550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased production of vascular endothelial growth factor by peripheral blood mononuclear cells in patients with inflammatory bowel disease.
    Griga T; Gutzeit A; Sommerkamp C; May B
    Eur J Gastroenterol Hepatol; 1999 Feb; 11(2):175-9. PubMed ID: 10102229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer.
    Chakra M; Pujol JL; Lamy PJ; Bozonnat MC; Quantin X; Jacot W; Daurès JP
    J Thorac Oncol; 2008 Oct; 3(10):1119-26. PubMed ID: 18827607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation of serum vascular endothelial growth factor as an angiogenesis biomarker with nitric oxide & urokinase-type plasminogen activator in breast cancer patients.
    Konukoglu D; Turhan MS; Celik V; Turna H
    Indian J Med Res; 2007 Jun; 125(6):747-51. PubMed ID: 17704550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical relevance of serum vascular endothelial growth factor (VEGF) in correlation to circulating tumor cells and other serum biomarkers in patients with metastatic breast cancer.
    Banys-Paluchowski M; Witzel I; Riethdorf S; Pantel K; Rack B; Janni W; Fasching PA; Aktas B; Kasimir-Bauer S; Hartkopf A; Solomayer EF; Fehm T; Müller V
    Breast Cancer Res Treat; 2018 Nov; 172(1):93-104. PubMed ID: 30003393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating vascular endothelial growth factor in cutaneous malignant melanoma.
    Pelletier F; Bermont L; Puzenat E; Blanc D; Cairey-Remonnay S; Mougin C; Laurent R; Humbert P; Aubin F
    Br J Dermatol; 2005 Apr; 152(4):685-9. PubMed ID: 15840099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)].
    Nadar SK; Blann A; Beevers DG; Lip GY
    J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.